FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: oncology

Sort
E.g., 2013-05-21
E.g., 2013-05-21
Enter a comma separated list of user names.

Power3 Medical Products, Inc. (PWRM.OB) previously has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc., a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy.

SGX Pharmaceuticals is a biopharmaceutical company which focuses mainly on the development and commercialization of new oncological, or cancer therapies. Yesterday, the company announced its submission of an Investigational New Drug (IND) application for FDA approval.

During the Jefferies 2nd Annual Healthcare Conference in New York, David S. Barlow, the chairman and CEO of Molecular Insight Pharmaceuticals, Inc. (MIPI) presented on the fast growing field of molecular medicine.

ADVERTISE WITH US